Pri-Med Podcasts

Acute Exacerbations of COPD: Challenges and Opportunities

Overview: Join pulmonologist Dr. Chris Fanta as he discusses acute exacerbations and COPD. The podcast begins with a typical case presentation seen in primary care which highlights the experience of acute exacerbations of COPD. Next, Dr. Fanta discusses the impact of COPD on the lives of patients and, lastly, discusses how COPD is treatable and, to some extent, preventable in an outpatient setting. Please note that any data, indications, and guidelines presented in this activity are current as of the recording 9/1/2020 and they are subject to change as new information is published.  Guest: Christopher H. Fanta, MD

Managing Heart Failure with Reduced Ejection Fraction in 2020

Overview: Join cardiologist Ty Gluckman, MD in part one of this two part podcast series as he reviews the latest guideline-based management of heart failure with reduced ejection fraction (HFrEF), bringing to light major advances in the past years and evidence supporting these advances.     Guest: Ty Gluckman, MD

Antibody Tests for COVID-19: What Do They Tell Us? - Frankly Speaking Ep 190

Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-190
Overview: A review of the latest evidence on antibody testing to identify current and past COVID-19 infection
Guest: Alan Ehrlich, MD
Music Credit: Richard Onorato

Influenza Management in 2020: What You Should Know about Prevention, Diagnosis, and Identifying Candidates for Treatment

Credits: 0.25 AMA PRA Category 1 Credit™ Claim CME/CE credit: https://pri-med.com/online-education/podcast/cme-podcast-influenza-genentech-1-pt1 Overview: In the first episode of this 3-part mini-series on influenza, infectious disease specialist, Daniel Solomon M.D., reviews the epidemiology of flu and discusses the importance of prevention and diagnosis during the current COVID-19 pandemic. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 8/26/2020 and they are subject to change as new information is published.

Influenza Immunization and Lower Mortality Rates in Diabetes - Frankly Speaking Ep 189

Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-189
Overview: This session will discuss an observational study performed in Denmark on how receiving the influenza vaccine affected diabetics long-term outcomes.
Guest: Jill Terrien, PhD, ANP-BC  
Music Credit: Richard Onorato

Hydroxychloroquine for COVID-19: Not Ready for Prime-Time - Frankly Speaking Episode 188

Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-188
Overview: A review of the latest evidence regarding hydroxychloroquine (HCQ) as treatment for SARS-CoV-2 infection.
Guest: Alan Ehrlich, MD
 

Vitamin D and COVID-19 - Frankly Speaking Episode 187

Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-187
Overview: This podcast will review what is known and theorized about vitamin D status, susceptibility to viral infections, and mortality from viral infections.
Guest: Alan Ehrlich, MD
Music Credit: Richard Onorato

COVID-19: School Closing, Prevention, and Prognosis - Frankly Speaking Episode 186

Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-186
Overview: This episode will review current literature on COVID-19 data.
Guest: Guest: Susan Feeney, DNP, FNP-BC, NP-C
Music Credit: Richard Onorato

Pain Points: Non-Steroidal Anti-Inflammatories in Clinical Practice

Credits: 0.25 AMA PRA Category 1 Credit™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/rems-podcast-4-nsaids-8-20  Overview: Nonsteroidal anti-inflammatory drugs (NSAIDs) are used for pain management in a variety of settings and for a variety of conditions. This podcast summarizes the evidence for efficacy as well as for toxicities associated with this drug class and outlines current guideline recommendations. This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA). Guest: Oscar A. De Leon-Casasola, MD

A Change In Treating Mild Asthma - Frankly Speaking Ep 185

Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-185
Overview: This episode will review a study of using LABA with inhaled steroid rather than a short acting rescue inhaler.
Guest: Guest: Alan Ehrlich, MD
Music Credit: Richard Onorato